Inebilizumab Biosimilar - Research Grade

Uses the same sequence as the therapeutic antibody Inebilizumab. Our biosimilar is not afucosylated

Detects human CD19

Human

CD19

Functional Assays

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

5mg/mL

<1EU/mg Determined by LAL gel clotting assay

≥95% monomer by analytical SEC, >95% by SDS Page

ICH3002

Blue ice

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.